Effectiveness of Dry Needling of the Sternocleidomastoid in Patients With Cervicogenic Headaches

July 21, 2020 updated by: Florida Gulf Coast University

Effectiveness of Dry Needling of the Sternocleidomastoid in Patients With Cervicogenic Headaches - A Randomized Clinical Trial

Evaluating the benefit of dry needling of the sternocleidomastoid muscle in subjects with cervicogenic headaches.

Study Overview

Status

Terminated

Intervention / Treatment

Detailed Description

The purpose of this study is to determine whether individuals with cervicogenic headache respond favorably to a program of manual therapy in combination with dry needling of the major muscle between chest bone and the head (sternocleidomastoid muscle) compared to manual therapy directed to the upper body quadrant alone.

The researchers will conduct a randomized clinical trial to assess the effectiveness of a manual therapy and dry needling approach (group 1) vs. manual therapy only. (group 2)

Study Type

Interventional

Enrollment (Actual)

17

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Indiana
      • Hobart, Indiana, United States, 46342
        • Integrated therapy Practice PC

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 63 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Age between 18-65 years old
  2. Primary complaint of cervicogenic headache
  3. Restricted cervical Range of motion
  4. Neck Disability Index > 20 points

Exclusion Criteria:

  1. Red flags identified during the patients physical therapy initial evaluation (i.e. tumor, fracture, metabolic diseases, RA, osteoporosis, prolonged history of steroid use, symptoms of vertebrobasilary insufficiency, pregnancy, cervical spinal stenosis, bilateral upper extremity symptoms etc.
  2. Use of blood thinners
  3. History of whiplash injury within the past six weeks
  4. Evidence of central nervous system involvement, to include hyperreflexia, sensory disturbances in the hand, intrinsic muscle wasting of the hands, unsteadiness during walking, nystagmus, loss of visual acuity, impaired sensation of the face, altered taste, the presence of pathological reflexes (i.e. positive Hoffman's and/or Babinski reflexes), etc.
  5. Two or more positive neurologic signs consistent with nerve root compression, including any two of the following:

    1. Muscle weakness involving a major muscle group of the upper extremity
    2. Diminished upper extremity muscle stretch reflex (biceps brachii, brachioradialis, or triceps)
    3. Diminished or absent sensation to pinprick in any upper extremity dermatome
  6. Prior surgery to the neck or thoracic spine
  7. Chiropractic, Physical Therapy, or Acupuncture treatment for their neck pain in the last 6-months
  8. Workers compensation or pending legal action regarding their headaches
  9. Insufficient English language skills to complete all questionnaires
  10. Inability to comply with treatment and follow-up schedule

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: standard care group
Normal manual therapy interventions Clinician will decide normal course of treatment
Experimental: Dry needling
Dryneedling group Clinician will decide normal course of treatment and dry needling of the Sternocleidomastoid muscle (SCM) muscle will be added to that treatment
Dryneedling of the sternocleidomastoid muscles within a standard treatment approach of physical therapy

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Headache Disability Index (HDI) score
Time Frame: At initial evaluation (day 1), week three (day 21) and week 6 (day 42)
Questionnaire for self report, this will be on a 0-100 score
At initial evaluation (day 1), week three (day 21) and week 6 (day 42)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in cervical range of motion using an inclinometer/ change in high cervical range of motion using the Flexion-Rotation Test (FRT)
Time Frame: At initial evaluation (day 1), week three (day 21) and week 6 (day 42)
range of motion assessment, this will be measured in degrees with standardized goniometer measure
At initial evaluation (day 1), week three (day 21) and week 6 (day 42)
Change in the neck disability Index score
Time Frame: At initial evaluation (day 1), week three (day 21) and week 6 (day 42)
Self report neck pain questionnaire, This is a 0-100 score
At initial evaluation (day 1), week three (day 21) and week 6 (day 42)
Change in visual analogue scale score
Time Frame: At initial evaluation (day 1), week three (day 21) and week 6 (day 42)
Pain intensity scale,on a 10 cm line patient is asked to mark pain with one vertical mark
At initial evaluation (day 1), week three (day 21) and week 6 (day 42)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Rob Sillevis, PhD, FGCU Assistent Professor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2018

Primary Completion (Actual)

March 1, 2020

Study Completion (Actual)

March 1, 2020

Study Registration Dates

First Submitted

October 29, 2018

First Submitted That Met QC Criteria

November 2, 2018

First Posted (Actual)

November 5, 2018

Study Record Updates

Last Update Posted (Actual)

July 23, 2020

Last Update Submitted That Met QC Criteria

July 21, 2020

Last Verified

July 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cervicogenic Headache

Clinical Trials on Dry needling

3
Subscribe